BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29843087)

  • 41. Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.
    Maura G; Billionnet C; Alla F; Gagne JJ; Pariente A
    Pharmacotherapy; 2018 Jan; 38(1):6-18. PubMed ID: 29028119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New oral anticoagulants for the treatment of acute venous thromboembolism: are they safer than vitamin K antagonists? A meta-analysis of the interventional trials.
    Loffredo L; Perri L; Del Ben M; Angelico F; Violi F
    Intern Emerg Med; 2015 Jun; 10(4):499-506. PubMed ID: 25539954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct Oral Anticoagulants and the Paradigm Shift in the Management of Venous Thromboembolism.
    Lim HY; Nandurkar H; Ho P
    Semin Thromb Hemost; 2018 Apr; 44(3):261-266. PubMed ID: 29558778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location.
    Janczak DT; Mimier MK; McBane RD; Kamath PS; Simmons BS; Bott-Kitslaar DM; Lenz CJ; Vargas ER; Hodge DO; Wysokinski WE
    Mayo Clin Proc; 2018 Jan; 93(1):40-47. PubMed ID: 29217335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Direct oral anticoagulants in patients with liver cirrhosis: A systematic review.
    Hoolwerf EW; Kraaijpoel N; Büller HR; van Es N
    Thromb Res; 2018 Oct; 170():102-108. PubMed ID: 30153564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. News in the Indications of Direct Oral Anticoagulants According to the American College of Chest Physicians 2016 Guidelines.
    Cesarman-Maus G; Ruiz-Argüelles GJ
    Curr Drug Metab; 2017; 18(7):651-656. PubMed ID: 28412908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct Oral Anticoagulants: Laboratory Challenges and Antidotes.
    Beyer-Westendorf J; Köhler C
    Hamostaseologie; 2023 Feb; 43(1):37-43. PubMed ID: 36807818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy.
    Finks SW; Trujillo TC; Dobesh PP
    Ann Pharmacother; 2016 Jun; 50(6):486-501. PubMed ID: 26917821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Barba M; Rohilla S; Terrenato I; Sperati F; Muti P; Schünemann HJ
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006650. PubMed ID: 18425959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An Update on the "Novel" and Direct Oral Anticoagulants, and Long-Term Anticoagulant Therapy.
    Djulbegovic M; Lee AI
    Clin Chest Med; 2018 Sep; 39(3):583-593. PubMed ID: 30122182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of acute venous thromboembolism among a cohort of patients discharged directly from the emergency department.
    Bungard TJ; Ritchie B; Bolt J; Semchuk WM
    BMJ Open; 2018 Oct; 8(10):e022064. PubMed ID: 30385439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
    Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
    BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands.
    de Jong LA; Dvortsin E; Janssen KJ; Postma MJ
    Clin Ther; 2017 Feb; 39(2):288-302.e4. PubMed ID: 28139289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimizing the safety of treatment for venous thromboembolism in the era of direct oral anticoagulants.
    Weitz JI; Jaffer IH
    Pol Arch Med Wewn; 2016 Sep; 126(9):688-696. PubMed ID: 27592622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticoagulation Management Practices and Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Clinical Research Study.
    Insam C; Méan M; Limacher A; Angelillo-Scherrer A; Aschwanden M; Banyai M; Beer JH; Bounameaux H; Egloff M; Frauchiger B; Husmann M; Kucher N; Lämmle B; Matter C; Osterwalder J; Righini M; Staub D; Rodondi N; Aujesky D
    PLoS One; 2016; 11(2):e0148348. PubMed ID: 26906217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
    Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
    Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease.
    Haas S; Farjat AE; Pieper K; Ageno W; Angchaisuksiri P; Bounameaux H; Goldhaber SZ; Goto S; Mantovani L; Prandoni P; Schellong S; Turpie AGG; Weitz JI; MacCallum P; Cate HT; Panchenko E; Carrier M; Jerjes-Sanchez C; Gibbs H; Jansky P; Kayani G; Kakkar AK;
    TH Open; 2022 Oct; 6(4):e354-e364. PubMed ID: 36452204
    [No Abstract]   [Full Text] [Related]  

  • 58. Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching study.
    Bartoli-Abdou JK; Patel JP; Crawshaw J; Vadher B; Brown A; Roberts LN; Patel RK; Arya R; Auyeung V
    Thromb Res; 2018 Feb; 162():62-68. PubMed ID: 29306122
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Analysis of the Risk Factors Associated with Minor Bleeding in Patients with Venous Thromboembolism during Treatment with Direct Oral Anticoagulants].
    Sunaga T; Shimizu T; Nakamura S; Takahashi N; Higashino M; Matsui M; Hozumi T; Ebato M; Suzuki H; Kogo M; Watanabe T; Sasaki T
    Yakugaku Zasshi; 2019; 139(3):461-467. PubMed ID: 30828024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of Direct Oral Anticoagulants Versus Traditional Therapies for Acute Venous Thromboembolism After Direct Discharge From the Emergency Department or After Hospitalization: An Audit of 16 Canadian Hospitals.
    Bungard TJ; Ritchie B; Bolt J; Thomson P; Semchuk WM
    Clin Ther; 2020 May; 42(5):873-881. PubMed ID: 32284189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.